Inhaler
Latest Astrazeneca UK Limited Patents:
- Antibodies that bind the spike protein of SARS-CoV-2
- COMBINATION OF ANTIBODY-DRUG CONJUGATE AND BISPECIFIC CHECKPOINT INHIBITOR
- Systems and methods for dispensing a statin medication over the counter
- Systems and methods for dispensing a statin medication over the counter
- COMBINATION OF AN ANTIBODY SPECIFIC FOR A TUMOR ANTIGEN AND A CD47 INHIBITOR
Description
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
U.S. Patent Documents
| D452910 | January 8, 2002 | Braithwaite et al. |
| D518171 | March 28, 2006 | Anderson et al. |
| D560793 | January 29, 2008 | Pearl et al. |
| D569967 | May 27, 2008 | Pearl et al. |
| D576724 | September 9, 2008 | Jensen et al. |
| D579544 | October 28, 2008 | Birath et al. |
| D590495 | April 14, 2009 | Lulla et al. |
| D590938 | April 21, 2009 | Lulla et al. |
| D636485 | April 19, 2011 | White et al. |
| D641076 | July 5, 2011 | Grunstad et al. |
| 20080236579 | October 2, 2008 | Zierenberg et al. |
| 20080295833 | December 4, 2008 | Rohrschneider et al. |
Patent History
Patent number: D659236
Type: Grant
Filed: Jan 11, 2011
Date of Patent: May 8, 2012
Assignee: Astrazeneca UK Limited (London)
Inventors: Kajsa Bobjer (Malmö ), Camilla Lundström (Malmö ), Mårten Rittfeldt (Malmö ), Jonas Svennberg (Malmö )
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/382,993
Type: Grant
Filed: Jan 11, 2011
Date of Patent: May 8, 2012
Assignee: Astrazeneca UK Limited (London)
Inventors: Kajsa Bobjer (Malmö ), Camilla Lundström (Malmö ), Mårten Rittfeldt (Malmö ), Jonas Svennberg (Malmö )
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/382,993
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)